Table 1 The number of referrals, first treatments, screen-detected cancers and stage at diagnosis for breast cancer in England for March–April 2019/20, 2020/21, and 2021/22.

From: The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England

 

Year

 

2019/2020

2020/2021

2021/2022

 

% (N)

% (N)

% (N)

aNumber of referrals

609,664

552,993

667,136

  Urgent referrals

71.2 (433,880)

76.8 (424,970)

76.9 (512,782)

  Routine referrals

28.8 (175,784)

23.2 (128,023)

23.1 (154,354)

a,bNumber of first treatments

49,050

37,770

49,963

  <50 years

16.3 (8012)

18.6 (7027)

14.3 (7156)

  50–69 years

49.0 (24,037)

46.6 (17,683)

51.9 (25,945)

  70+ years

34.7 (17,001)

34.6 (13,060)

33.7 (16,862)

cNumber of screen-detected cancers

17,714

10,835

Awaited

dNumber of invasive cancers

45,560

37,309

47,493

  Stage 1

32.5 (14,829)

27.6 (10,296)

30.6 (14,543)

  Stage 2

30.7 (13,969)

32.6 (12,170)

30.5 (14,486)

  Stage 3

7.7 (3524)

8.3 (3105)

6.7 (3163)

  Stage 4

3.1 (1390)

3.9 (1451)

3.2 (1522)

  Unknown

26.0 (11,848)

27.6 (10,287)

29.0 (13,779)

  1. Data shown are publicly available at:
  2. aCancer Waiting Time data at NHS England https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/
  3. bCOVID-19 Cancer Equity data packs http://www.ncin.org.uk/local_cancer_intelligence/cadeas#covid-19
  4. cBreast Screening Programme https://digital.nhs.uk/data-and-information/publications/statistical/breast-screening-programme
  5. dCOVID-19 Rapid Cancer Registration and Treatment Data https://www.cancerdata.nhs.uk/covid-19/rcrd